The Healthy Elderly Longevity Cohort Study

This is an observational study called The Healthy Elderly Longevity Cohort. It aims to create a collection of biological samples (a biorepository) over ten years to help researchers understand healthy aging. You may be able to join if you are 80 years or older, can provide blood and/or saliva samples, and are willing to follow study procedures. You should also be generally healthy or have only mild medical conditions like well-controlled high blood pressure. The study is looking for 5000 participants. The current recruitment status is unclear.

Study design
This is an observational study with a planned enrollment of 5000 participants. It does not specify a phase.
What's involved
You would need to be eligible for blood and/or saliva collection and be willing to comply with all study procedures. The primary goal is to create a biorepository over ten years.
Compensation
Not stated in the trial record.
Follow-up
The primary endpoint, Biorepository Creation, is measured at ten years, suggesting a long-term follow-up period.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT01004133

The Healthy Elderly Longevity Cohort

Recruiting
Not specifiedAges 80+Observational
Scripps Translational Science Institute
~5,000 participants
Updated 2025-01-17 on ClinicalTrials.gov

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Biorepository Creation
Measured over ten years
Healthy
1 sites across 1 states
California1

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Hypertension, well controlled (no more than 3 medications)
Osteoporosis, Osteopenia and/or osteoarthritis
Benign prostatic hypertrophy
Cataracts, Glaucoma, Macular Degeneration
Dyslipidemia
Hypothyroidism
Pre-diabetes/impaired fasting glucose (fasting blood glucose 100-126 mg/dL, if known)

Exclusion

Any Cancer (including polycythemia; excluding basal or squamous cell skin cancer).
Coronary Artery Disease/Myocardial Infarction
Stroke/TIA
Deep Vein Thrombosis/Pulmonary Embolus
Chronic Renal Disease/Hemodialysis
Significant Auto-immune/Inflammatory conditions such as (Rheumatoid Arthritis, Lupus, Crohn's, etc.
Alzheimer's/Parkinson's
Diabetes (Hemoglobin A1C \> 6.5 % or fasting glucose \>126 mg/dL or treated with oral diabetic medication or insulin if known)
Aortic or Cerebral Aneurysm 5. Currently taking any of the following medications on a regular basis:
Oral chemotherapeutic agents (ex.: tamoxifen, doxorubicin, mitoxantrone, bleomycin)
Anti-platelet agents, not including aspirin (ex.: clopidogrel/plavix, dipyridamole/aggrenox/persantine, ticlopidine/ticlid)
Cholinesterase inhibitor for Alzheimer's disease (i.e. donepezil/Aricept)
Insulin 6. Subject has a significant medical condition which, in the Investigator's opinion, may interfere with the patient's optimal participation in the study or would potentially confound interpretation of the individual's phenotype.
  • Biorepository Creationten years

    Create a biorepository from participants' blood and/or saliva donations we will ultimately be able to define genes for various diseases and understand health